BP003450: Human IL-13 Protein with No Tag
Source: The recombinant Human IL-13 Protein, (amino acids Gly21-Asn132) fused with No Tag, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human IL-13, No tag at 2 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Human IL-13 Ra 2, hFc tag with the EC50 of 0.91 ug/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP004836: Human IL-13 Protein with the N-hFc Tag
Source: The recombinant Human IL-13 Protein, (amino acids Gly21-Asn132) fused with a hFc tag at the N-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Biotinylated Human IL-13Ra1 protein with the N-hFc tag at 2 ug/ml (100 ul/well) on the streptavidin precoated plate (5 ug/ml). Dose response curve for the recombinant Human IL-13 protein with the N-hFc tag with the EC50 of 15.8 ng/ml determined by ELISA (QC Test). The affinity constant of 0.399 uM as determined in SPR assay (Biacore T200).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP005417: Human IL-13 Protein with the N-His-Avi Tag
Source: The recombinant Human IL-13 Protein, (amino acids Gly21-Asn132) fused with a His-Avi tag at the N-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human IL-13 protein with the N-His-Avi tag at 2 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Human IL-13Ra2 protein with the N-hFc tag with the EC50 of 1.0 ug/ml determined by ELISA (QC Test). The affinity constant of 1 uM as determined in SPR assay (Biacore T200).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP002450-CA25: Recombinant Human Interleukin-28B (IL-28B) Protein
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).- BP000085-CYT-135: Recombinant Human Interferon-alpha 14 (IFNA14) Protein
Source: E. coli-derived.
Purity > 90% as determined by SDS-PAGE. BP000151-CYT-104: Recombinant Human IL-28A, HEK
Source: HEK-derived.
The specific activity was determined by the dose dependent protection of the cytopathic effect on A549 cells (human lung adenocarcinoma epithelial cell line) that were challenged with encephalomyocarditis (EMC) virus and is typically 0.5-5 ug/ml.
Purity: > 95% as obsereved by SDS-PAGE.BP000151-CYT-602: Recombinant Human IL-28A
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000152-CYT-117: Recombinant Human IL-29, HEK
Source: HEK-derived.
The specific activity was determined by the dose dependent protection of the cytopathic effect on A549 cells (human lung adenocarcinoma epithelial cell line) that were challenged with encephalomyocarditis (EMC) virus and is typically 0.5-5 ug/ml.
Purity: > 95% as obsereved by SDS-PAGE.BP000152-CYT-603: Recombinant Human IL-29
Source: E. coli-derived.
Purity > 90%, by SDS-PAGE and RP-HPLC.BP000498-PRO-561: Human Lambda Light Chain (LLC) Protein
Source: Pooled Bence Jones urine-derived.
Purity: > 96%.BP000728-ENZ-286: Recombinant T4 DNA Ligase
Source: Escherichia Colilambda lysogen NM 989-derived.
Incubation of a 50µl reaction containing 13,000 units of T4 DNA Ligase with 1µg of a mixture of single and double-stranded [3H] E. coli DNA (200,000 cpm/ug) for 4 hours at 37C released < 0.3% of the total radioactivity.
One Weiss unit is equivalent to circa 67 cohesive-end ligation units.T4 DNA Ligase is strongly inhibited by NaCl or KCl if the concentration is > 200 mM.BP002450-CYT-105: Recombinant Human Interleukin-28B (IL-28B) Protein
Source: HEK-derived.
The specific activity was determined by the dose dependent protection of the cytopathic effect on A549 cells (human lung adenocarcinoma epithelial cell line) that were challenged with encephalomyocarditis (EMC) virus and is typically 0.1-1 ng/ml.
Purity: > 95% as obsereved by SDS-PAGE.